J.W. Burns & Co’s Allergan plc AGN Stock Holding History

J.W. Burns & Co’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-906	Closed	-$220K	–	160
2017 Q2	$220K	Buy	906 +6	+0.7%	+$1.41K	0.06%	151
2017 Q1	$215K	Buy	+900	New	+$210K	0.06%	154
2016 Q4	–	Sell	-900	Closed	-$207K	–	162
2016 Q3	$207K	Hold	900	–	–	0.06%	148
2016 Q2	$208K	Hold	900	–	–	0.06%	146
2016 Q1	$241K	Sell	900 -25	-3%	-$7.16K	0.08%	139
2015 Q4	$289K	Buy	925 +25	+3%	+$7.44K	0.09%	130
2015 Q3	$245K	Hold	900	–	–	0.08%	136
2015 Q2	$273K	Hold	900	–	–	0.09%	136
2015 Q1	$268K	Hold	900	–	–	0.09%	138
2014 Q4	$232K	Hold	900	–	–	0.08%	145
2014 Q3	$217K	Buy	+900	New	+$201K	0.07%	149

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

J.W. Burns & Co's AGN Position: Q3 2017 in Review

J.W. Burns & Co sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 906 shares — an estimated $220K sold.

J.W. Burns & Co first reported a position in AGN in Q3 2014 and held it in 11 quarters. The position peaked at $289K in Q4 2015. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

J.W. Burns & Co reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
J.W. Burns & Co sold 906 Allergan plc shares in Q3 2017, an estimated $220K.
J.W. Burns & Co first reported a position in Allergan plc in Q3 2014 and held it in 11 quarters.
J.W. Burns & Co's Allergan plc position peaked at $289K in Q4 2015.
1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on J.W. Burns & Co's 13F filing for Q3 2017, filed 10 Oct 2017.